NANCY J. WYSENSKI

Corporate Board Profile

Tech Score: 0/100

INOVIO PHARMACEUTICALS, INC.

Filing Date	Source Excerpt
2015-03-20	Nancy J. Wysenski joined our Board in March 2015 and brings extensive health care experience and proven leadership in managing growth-oriented companies. ... Nancy J. Wysenski joined the Nomination and Corporate Governance Committee in March 2015.
2016-03-25	Nancy J. Wysenski joined our Board in March 2015 and qualifies to serve on our Board as she brings extensive health care experience and proven leadership in managing growth-oriented companies. The members of the Compensation Committee currently are Morton Collins (Chair), Simon Benito, Adel Mahmoud and Nancy Wysenski. Each member of the Compensation Committee is independent under the NASDAQ listing standards. The members of the Nomination and Corporate Governance Committee currently are Angel Cabrera (Chair), Avtar Dhillon, Adel Mahmound and Nancy Wysenski. Each member of the Nomination and Corporate Governance Committee is independent under the NASDAQ listing standards. Non-Employee Director Compensation Program: Ms. Wysenski received total compensation of $203,380 in 2015.

Filing Date

Source Excerpt

2015-03-20

Nancy J. Wysenski joined our Board in March 2015 and brings extensive health care experience and proven leadership in managing growth-oriented companies. ... Nancy J. Wysenski joined the Nomination and Corporate Governance Committee in March 2015.

2016-03-25

Nancy J. Wysenski joined our Board in March 2015 and qualifies to serve on our Board as she brings extensive health care experience and proven leadership in managing growth-oriented companies. The members of the Compensation Committee currently are Morton Collins (Chair), Simon Benito, Adel Mahmoud and Nancy Wysenski. Each member of the Compensation Committee is independent under the NASDAQ listing standards. The members of the Nomination and Corporate Governance Committee currently are Angel Cabrera (Chair), Avtar Dhillon, Adel Mahmound and Nancy Wysenski. Each member of the Nomination and Corporate Governance Committee is independent under the NASDAQ listing standards. Non-Employee Director Compensation Program: Ms. Wysenski received total compensation of $203,380 in 2015.

Data sourced from SEC filings. Last updated: 2026-03-05